J Virol 2001, 81: 12846–58.CrossRef 27. Varki A: Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature 2007, 446: 1023–9.CrossRefPubMed 28. Ohyama C: Glycosylation JIB04 clinical trial in bladder cancer. Int J Clin Oncol 2008, 13: 308–13.CrossRefPubMed 29. Guthmann MD, Bitton RJ, Carnero AJ, Gabri MR, Cinat G, Koliren L, Lewi D, Fernandez LE, Alonso DF, Gómez DE, Fainboim L: Active specific immunotherapy of melanoma with a GM3 ganglioside-based vaccine: a report on safety and immunogenicity. J Immunother 2004, 27: 442–51.CrossRefPubMed 30. Gu Y, Zhang J, Mi W, Yang J, Han F, Lu X, Yu W: Silencing of GM3 synthase

suppresses lung metastasis of murine breast cancer cells. Breast Cancer Res 2008, 10: R1.CrossRefPubMed 31. Ecsedy JA, Manfredi MG, Yohe HC, Seyfried TN: Ganglioside

biosynthetic gene expression in experimental mouse brain tumors. Cancer Res 1997, 57: 1580–3.PubMed 32. Seyfried TN, el-Abbadi M, Ecsedy JA, Bai HW, Yohe HC: BTK inhibitor Influence of host cell infiltration on the glycolipid content of mouse brain tumors. J Neurochem 1996, 66: 2026–33.CrossRefPubMed 33. Oliva JP, Valdés Z, Casacó A, Pimentel G, González J, Alvarez I, Osorio M, Velazco M, Figueroa M, Ortiz R, Escobar X, Orozco M, Cruz J, Franco S, Díaz M, Roque L, Carr A, Vázquez AM, Mateos C, Rubio MC, Pérez R, Fernández LE: Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled Tau-protein kinase with (99 m)Tc. Breast Cancer Res Treat 2006, 96: 115–21.CrossRefPubMed 34. Malykh YN, Schauer R, Shaw L: MRT67307 nmr N-Glycolylneuraminic acid in human tumors. Biochimie 2001, 83: 623–34.CrossRefPubMed 35. Scursoni AM, Galluzzo L, Camarero S, Pozzo N, Gabri MR, Mateo de Acosta C, Vazquez

AM, Alonso DF, G de Dávila MT: Detection and characterization of n-glycolylated gangliosides in wilms tumor by immunohistochemistry. Pediatr Dev Pathol 2009, in press. 36. Yin J, Hashimoto A, Izawa M, Miyazaki K, Chen GY, Takematsu H, Kozutsumi Y, Suzuki A, Furuhata K, Cheng FL, Lin CH, Sato C, Kitajima K, Kannagi R: Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells. Cancer Res 2006, 66: 2937–45.CrossRefPubMed 37. Carraway KL, Perez A, Idris N, Jepson S, Arango M, Komatsu M, Haq B, Price-Schiavi SA, Zhang J, Carraway CA: Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive. Prog Nucleic Acid Res Mol Biol 2002, 71: 149–85.CrossRefPubMed 38. Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, Dahiya R, Kim YS: Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 1993, 53: 641–51.PubMed 39. Fernandez LE, Alonso DF, Gomez DE, Vazquez AM: Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer. Expert Rev Vaccines 2003, 2: 817–823.CrossRefPubMed 40.